All News #Library
Biotech
Windward Bio Expands Pipeline with WIN-027 Bispecific Antibody
22 Dec 2025 //
GLOBENEWSWIRE
Windward Bio Begins Global Phase 2 Asthma Trial for WIN378
23 Jul 2025 //
GLOBENEWSWIRE
Windward Bio Begins Global Phase 2 Asthma Trial of SKB378/WIN378
23 Jul 2025 //
PR NEWSWIRE
Windward Bio Launches With $200M Series A For Anti-TSLP Antibody
10 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support